Indications and Purposes
| 1 Indications And Usage Hemlibra Is Indicated For Routine Prophylaxis To Prevent Or Reduce The Frequency Of Bleeding Episodes In Adult And Pediatric Patients Ages Newborn And Older With Hemophilia A (Congenital Factor Viii Deficiency) With Or Without Factor Viii Inhibitors. Hemlibra Is A Bispecific Factor Ixa- And Factor X-Directed Antibody Indicated For Routine Prophylaxis To Prevent Or Reduce The Frequency Of Bleeding Episodes In Adult And Pediatric Patients Ages Newborn And Older With Hemophilia A (Congenital Factor Viii Deficiency) With Or Without Factor Viii Inhibitors. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Emicizumab |